The World Health Organization (WHO) has published its first-ever report addressing the lack of medicines and diagnostic tools for invasive fungal diseases.
According to a new study, by researchers at Danderyd Hospital and Karolinska Institutet in Sweden, 1 in 10 people still experience symptoms of COVID-19 8 months after infection.
Jarek Salek, Head of Engineering and Technical Operations at Uvisan, explains how UV-C cleaning in educational facilities can make shared equipment safe from COVID and help resume teaching that involves computers and other shared hardware.
Scientists at the University of Pittsburgh are creating COVID-19 antibodies in llamas, to understand how humans could engineer better immune responses.
Ann G. Matthysse, Professor of Biology from The University of North Carolina at Chapel Hill, writes in detail about plague, the first pandemic disease including comment on bacteria.
Andrew Metcalfe, Biotech Specialist at LumiBio discusses the persistent problem of hospital-acquired infections, and why now is the time to focus on reducing COVID- 19 transmission in clinical settings using the LumiBio solution.
According to a new study, COVID-19 infection in pregnancy is not associated with stillbirth or early neonatal death but it may increase the risk of pre-term birth.
Ruth Smith CEO of Active Care Group and its Christchurch Group division discusses the new highly virulent variant of COVID, vaccinations, and infection prevention and control (IPC).
Four new research studies looking into Long COVID in the community will receive funding worth £18.5 million from UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR).
